3.0.0 1681 2023-01-11T13:43:53Z 2023-01-11T13:43:53Z Senate S 2019-05-23 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Discharged from 2020-12-17T23:58:28Z Referred to 2019-05-23T21:03:19Z 2020-12-18 14:52:26 Held at the desk. Floor H15000 2 House floor actions 2020-12-18 14:14:15 Received in the House. Floor H14000 2 House floor actions 2020-12-18 Senate Message on Senate action sent to the House. Floor 2020-12-17 Senate Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7643) Floor 2020-12-17 Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent. Floor 17000 9 Library of Congress 2020-12-17 Senate Measure laid before Senate by unanimous consent. (consideration: CR S7642-7643) Floor 2020-12-17 sshr00 Health, Education, Labor, and Pensions Committee Senate Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. Discharge 2020-12-17 Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. Committee 14500 9 Library of Congress sshr00 Health, Education, Labor, and Pensions Committee 2019-05-23 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2019-05-23 Introduced in Senate IntroReferral 10000 9 Library of Congress E000285 Sen. Enzi, Michael B. [R-WY] MICHAEL ENZI R WY B. N H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH 2019-05-23 True Health Drug safety, medical device, and laboratory regulation Government information and archives Health personnel Immunology and vaccination Licensing and registrations Manufacturing Medical education Medicare Prescription drugs Health 00 2019-05-23 Introduced in Senate 2021-09-13T16:10:02Z Advancing Education on Biosimilars Act of 2019

This bill addresses education for the public and for health care providers regarding biosimilars. (Biosimilars are biological products approved by the Food and Drug Administration based on their similarity to an already approved biological product.)

The bill requires the Department of Health and Human Services (HHS) to create a website for educational materials on the meaning and use of biosimilars and interchangeable biological products.

HHS must also develop or improve continuing medical education programs for health care providers regarding biosimilars.

]]> 55 2020-12-17 Passed Senate 2021-09-13T16:04:53Z Advancing Education on Biosimilars Act of 2020

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)

The FDA may also maintain and operate a website to provide educational materials about biological products.

]]> Advancing Education on Biosimilars Act of 2020 Display Title Advancing Education on Biosimilars Act of 2020 Short Title(s) as Introduced Advancing Education on Biosimilars Act of 2019 Introduced in Senate IS Short Title(s) as Passed Senate Advancing Education on Biosimilars Act of 2020 S Senate Engrossed in Senate ES Short Titles as Passed Senate Advancing Education on Biosimilars Act of 2020 S Senate Official Title as Introduced A bill to educate health care providers and the public on biosimilar biological products, and for other purposes. Introduced in Senate IS 2716 116 SAMDT In the nature of a substitute. 2022-02-08T23:03:56Z 2020-12-17 Amendment SA 2716 agreed to in Senate by Unanimous Consent. SA 2716 https://www.congress.gov/amendment/116th-congress/senate-amendment/2716 A000360 Sen. Alexander, Lamar [R-TN] Lamar Alexander R TN 2020-12-17T05:00:00Z 2020-12-17T05:00:00Z Senate 116 S Senate S 1681 Advancing Education on Biosimilars Act of 2020 2023-01-11T13:43:53Z 6 2020-12-17 0 Senate Amendment SA 2716 agreed to in Senate by Unanimous Consent. Floor 2020-12-17 0 Senate Amendment SA 2716 proposed by Senator Braun for Senator Alexander. (consideration: CR S7643; text: CR S7643) In the nature of a substitute. Floor 2020-12-17 Senate amendment submitted Floor 91000 9 Library of Congress 2020-12-17 Senate amendment proposed (on the floor): Amendment SA 2716 proposed by Senator Braun for Senator Alexander. Floor 93000 9 Library of Congress 2020-12-17 Senate amendment agreed to: Amendment SA 2716 agreed to in Senate by Unanimous Consent. Floor 94000 9 Library of Congress Engrossed in Senate 2020-12-17T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s1681es/xml/BILLS-116s1681es.xml Introduced in Senate 2019-05-23T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s1681is/xml/BILLS-116s1681is.xml 2020-12-18 Held at the desk. 14:52:26 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.